| Haber: |
Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: FDA decision on Novavax Covid shot could be delayed; new drug prices rose 20% annually in recent years
The FDA needs to review changes to the manufacturing process used by Novavax before it can authorize the company’s Covid-19 vaccine.
https://www.statnews.com/pharmalot/2022/06/09/covid19-vaccine-novavax-patents-drug-prices-generics-antitrust-fda/?utm_campaign=rss
|
